AVAILABILITY OF MEDICINES FOR CHILDREN: ISSUES OF REGULATORY IMPROVEMENT
Objective: to analyze the factors limiting the availability of medicines for children and to substantiate directions for regulatory improvement in the Russian Federation. Materials and methods: a narrative (targeted) review of WHO documents, legal and regulatory acts of the EU, USA, China, Russia and the EAEU, as well...